Lansoprazole is an antituberculous prodrug targeting cytochrome bc1
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Lansoprazole is an antituberculous prodrug targeting cytochrome bc1
Authors
Keywords
-
Journal
Nature Communications
Volume 6, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-07-09
DOI
10.1038/ncomms8659
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Respiratory Flexibility in Response to Inhibition of CytochromecOxidase in Mycobacterium tuberculosis
- (2014) Kriti Arora et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Anticytolytic Screen Identifies Inhibitors of Mycobacterial Virulence Protein Secretion
- (2014) Jan Rybniker et al. Cell Host & Microbe
- Towards a new combination therapy for tuberculosis with next generation benzothiazinones
- (2014) V. Makarov et al. EMBO Molecular Medicine
- Structural analysis of atovaquone-inhibited cytochrome bc1 complex reveals the molecular basis of antimalarial drug action
- (2014) Dominic Birth et al. Nature Communications
- Fueling Open-Source Drug Discovery: 177 Small-Molecule Leads against Tuberculosis
- (2013) Lluís Ballell et al. ChemMedChem
- Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis
- (2013) Kevin Pethe et al. NATURE MEDICINE
- Platforms for antibiotic discovery
- (2013) Kim Lewis NATURE REVIEWS DRUG DISCOVERY
- Advances in the development of new tuberculosis drugs and treatment regimens
- (2013) Alimuddin Zumla et al. NATURE REVIEWS DRUG DISCOVERY
- Identification of Novel Imidazo[1,2-a]pyridine Inhibitors Targeting M. tuberculosis QcrB
- (2013) Katherine A. Abrahams et al. PLoS One
- Identification of Novel Inhibitors of M. tuberculosis Growth Using Whole Cell Based High-Throughput Screening
- (2012) Sarah A. Stanley et al. ACS Chemical Biology
- In VitroCombination Studies of Benzothiazinone Lead Compound BTZ043 against Mycobacterium tuberculosis
- (2012) Benoit Lechartier et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Streptomycin-Starved Mycobacterium tuberculosis 18b, a Drug Discovery Tool for Latent Tuberculosis
- (2012) Ming Zhang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Towards a new tuberculosis drug: pyridomycin - nature's isoniazid
- (2012) Ruben C. Hartkoorn et al. EMBO Molecular Medicine
- Liver-stage malaria parasites vulnerable to diverse chemical scaffolds
- (2012) E. R. Derbyshire et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Fast Standardized Therapeutic-Efficacy Assay for Drug Discovery against Tuberculosis
- (2010) J. Rullas et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A chemical genetic screen in Mycobacterium tuberculosis identifies carbon-source-dependent growth inhibitors devoid of in vivo efficacy
- (2010) Kevin Pethe et al. Nature Communications
- Prodrugs: design and clinical applications
- (2008) Jarkko Rautio et al. NATURE REVIEWS DRUG DISCOVERY
- Revisiting the host as a growth medium
- (2008) Stacie A. Brown et al. NATURE REVIEWS MICROBIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation